There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Related collections

Data availability:

Comments

Comment on this article

Cited by 1

Targeted Therapy in Advanced and Metastatic Non-Small Cell Lung Cancer. An Update on Treatment of the Most Important Actionable Oncogenic Driver Alterations
Authors: David König, Spasenija Savic Prince, Sacha Rothschild

See all cited by

Lorlatinib vs crizotinib in the first-line treatment of patients (pts) with advanced ALK-positive non-small cell lung cancer (NSCLC): Results of the phase III CROWN study

Read this article at

Related collections

Model Reduction of Parametrized Systems 2015

Comments

Comment on this article

Similar content 2,247

Cited by 1